Wei Xu Selected Research

Wei Xu Research Topics

Disease

490	Neoplasms (Cancer) 12/2022 - 08/2002
117	Infections 09/2022 - 01/2001
97	Neoplasm Metastasis (Metastasis) 06/2022 - 01/2006
87	Inflammation (Inflammations) 12/2022 - 02/2008
70	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2022 - 06/2006
62	Carcinoma (Carcinomatosis) 02/2022 - 08/2002
55	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 01/2009
54	Breast Neoplasms (Breast Cancer) 10/2022 - 10/2007
51	Melanoma (Melanoma, Malignant) 01/2022 - 02/2009
44	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2007
42	Carcinogenesis 01/2022 - 06/2007
41	Stomach Neoplasms (Stomach Cancer) 04/2022 - 12/2009
40	Fibrosis (Cirrhosis) 07/2022 - 08/2006
39	Lung Neoplasms (Lung Cancer) 12/2022 - 08/2005
38	COVID-19 07/2022 - 01/2020
30	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 10/2010
30	Hypoxia (Hypoxemia) 01/2022 - 03/2003
28	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2022 - 08/2008
27	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2012
25	Lymphoma (Lymphomas) 11/2021 - 04/2003
24	Myocarditis (Carditis) 07/2021 - 02/2004
23	Stroke (Strokes) 11/2022 - 04/2013
23	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2010
23	Leukemia 01/2022 - 04/2003
22	Head and Neck Neoplasms (Head and Neck Cancer) 02/2022 - 04/2011
22	Cognitive Dysfunction 01/2022 - 06/2008
22	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 10/2007
20	Obesity 11/2022 - 01/2012
20	Atrial Fibrillation 08/2022 - 01/2012
19	Necrosis 11/2022 - 11/2002
19	Hemorrhage 11/2022 - 01/2006
18	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 10/2006
17	Adenocarcinoma 01/2021 - 05/2009
17	Ischemia 12/2019 - 11/2002
16	Ulcerative Colitis 12/2022 - 07/2007
16	Dementia (Dementias) 09/2022 - 01/2019
16	Body Weight (Weight, Body) 03/2022 - 09/2012
16	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 11/2010
15	Prostatic Neoplasms (Prostate Cancer) 09/2022 - 01/2010
15	Wounds and Injuries (Trauma) 05/2022 - 06/2005
14	Pain (Aches) 09/2022 - 12/2012
14	Adenocarcinoma of Lung 04/2022 - 10/2010
14	Atherosclerosis 01/2022 - 10/2009
14	Neuroinflammatory Diseases 01/2022 - 03/2013
14	Virus Diseases (Viral Diseases) 01/2022 - 08/2004
14	Lymphatic Metastasis 01/2021 - 08/2005
14	Multiple Myeloma 07/2020 - 11/2006
13	Disease Progression 07/2022 - 10/2008
13	Reperfusion Injury 03/2022 - 08/2011
13	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2009
13	Hypertension (High Blood Pressure) 01/2022 - 05/2015

Drug/Important Bio-Agent (IBA)

172	Proteins (Proteins, Gene)FDA Link 02/2022 - 02/2006
115	Biomarkers (Surrogate Marker)IBA 09/2022 - 08/2009
69	Pharmaceutical PreparationsIBA 12/2022 - 04/2007
62	Biological ProductsIBA 04/2022 - 04/2003
57	Messenger RNA (mRNA)IBA 04/2022 - 04/2003
57	MicroRNAs (MicroRNA)IBA 01/2022 - 04/2006
45	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2004
39	CytokinesIBA 04/2022 - 04/2004
38	Therapeutic UsesIBA 12/2022 - 04/2007
34	Peptides (Polypeptides)IBA 11/2022 - 02/2004
30	Antiviral Agents (Antivirals)IBA 04/2022 - 06/2013
29	VaccinesIBA 05/2022 - 02/2004
28	CateninsIBA 01/2022 - 11/2012
27	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 07/2007
25	Small Interfering RNA (siRNA)IBA 01/2022 - 05/2006
23	RNA (Ribonucleic Acid)IBA 12/2022 - 03/2007
22	AntigensIBA 11/2022 - 08/2007
21	LipopolysaccharidesIBA 01/2022 - 11/2008
21	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 03/2003
20	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2006
19	Long Noncoding RNAIBA 04/2022 - 10/2016
19	Amyloid (Amyloid Fibrils)IBA 01/2022 - 08/2015
19	Rituximab (Mabthera)FDA Link 01/2021 - 04/2007
18	AntibodiesIBA 03/2022 - 02/2006
18	Interleukin-6 (Interleukin 6)IBA 03/2022 - 04/2003
16	ErbB Receptors (EGF Receptor)IBA 02/2022 - 03/2015
16	EnzymesIBA 01/2022 - 04/2009
16	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 12/2007
16	Cisplatin (Platino)FDA LinkGeneric 11/2021 - 08/2009
15	C-Reactive ProteinIBA 08/2022 - 12/2012
15	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2005
15	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 12/2010
14	LipidsIBA 11/2022 - 08/2012
14	Oxygen (Dioxygen)IBA 01/2022 - 10/2007
14	Estrogen ReceptorsIBA 01/2022 - 03/2009
14	Indicators and Reagents (Reagents)IBA 01/2022 - 12/2010
14	coactivator-associated arginine methyltransferase 1IBA 12/2021 - 03/2011
14	LigandsIBA 11/2021 - 09/2009
14	Phosphotransferases (Kinase)IBA 01/2020 - 11/2006
13	AlbuminsIBA 08/2022 - 05/2005
13	Immunoglobulin G (IgG)IBA 01/2022 - 06/2009

Therapy/Procedure

243	Therapeutics 01/2023 - 08/2002
84	Drug Therapy (Chemotherapy) 11/2022 - 11/2006
68	Radiotherapy 02/2022 - 08/2002
29	Immunotherapy 01/2022 - 10/2007
17	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2022 - 05/2011
17	Transplantation 01/2021 - 05/2005
16	Neoadjuvant Therapy 09/2022 - 01/2009
13	Length of Stay 01/2022 - 03/2013